Johanna Friedl-Naderer, EVP & COO: Vir Biotechnology VIR Sell · Filed 23/03/07

Trade details

Type: Insider sale
Amount: $33,819.24
Shares · price: 1,482 sh · $22.82 a share
Held after: 148,518 sh
Stock: Vir Biotechnology VIR
Person: Johanna Friedl-NadererEVP & COO
Trade date: 23/03/03
Filed: 23/03/07
Days to filing: 4 days

Sold 1.0% of holdings

Share of holding sold: 1.0%

Vir Biotechnology trades, last 26 weeks

What else happened in Vir Biotechnology around then

Filed or reported within 30 days of the trade day · 23/02/01~23/04/02

Johanna Friedl-Naderer's recent trades

Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,658
145 sh
$2,658
Filed 06/17
Traded 06/16
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$4,186
228 sh
$4,186
Filed 05/14
Traded 05/13
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,205
148 sh
$2,205
Filed 03/06
Traded 03/05
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,984
144 sh
$2,984
Filed 25/12/05
Traded 25/12/05
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$11.9K
894 sh
$11.9K
Filed 25/09/08
Traded 25/09/04

Johanna Friedl-Naderer, COO — sold $33.8K of Vir Biotechnology VIR · 1.0% of holdings | Whalegun